nodes	percent_of_prediction	percent_of_DWPC	metapath
Dicyclomine—Paraesthesia—Losartan—coronary artery disease	0.000418	0.000629	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Captopril—coronary artery disease	0.000417	0.000628	CcSEcCtD
Dicyclomine—Urticaria—Telmisartan—coronary artery disease	0.000417	0.000628	CcSEcCtD
Dicyclomine—Vomiting—Clopidogrel—coronary artery disease	0.000417	0.000627	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Furosemide—coronary artery disease	0.000416	0.000626	CcSEcCtD
Dicyclomine—Fatigue—Furosemide—coronary artery disease	0.000415	0.000625	CcSEcCtD
Dicyclomine—Abdominal pain—Telmisartan—coronary artery disease	0.000415	0.000625	CcSEcCtD
Dicyclomine—Dyspnoea—Losartan—coronary artery disease	0.000415	0.000624	CcSEcCtD
Dicyclomine—Vomiting—Lovastatin—coronary artery disease	0.000414	0.000623	CcSEcCtD
Dicyclomine—Somnolence—Losartan—coronary artery disease	0.000413	0.000622	CcSEcCtD
Dicyclomine—Dizziness—Eplerenone—coronary artery disease	0.000413	0.000622	CcSEcCtD
Dicyclomine—Rash—Clopidogrel—coronary artery disease	0.000413	0.000622	CcSEcCtD
Dicyclomine—Dermatitis—Clopidogrel—coronary artery disease	0.000413	0.000621	CcSEcCtD
Dicyclomine—Asthenia—Valsartan—coronary artery disease	0.000412	0.000621	CcSEcCtD
Dicyclomine—Hypertension—Timolol—coronary artery disease	0.000412	0.000621	CcSEcCtD
Dicyclomine—Constipation—Furosemide—coronary artery disease	0.000412	0.00062	CcSEcCtD
Dicyclomine—Pain—Furosemide—coronary artery disease	0.000412	0.00062	CcSEcCtD
Dicyclomine—Hypersensitivity—Niacin—coronary artery disease	0.000412	0.00062	CcSEcCtD
Dicyclomine—Ill-defined disorder—Lisinopril—coronary artery disease	0.000411	0.000619	CcSEcCtD
Dicyclomine—Discomfort—Ramipril—coronary artery disease	0.000411	0.000619	CcSEcCtD
Dicyclomine—Asthenia—Olmesartan—coronary artery disease	0.00041	0.000618	CcSEcCtD
Dicyclomine—Headache—Clopidogrel—coronary artery disease	0.00041	0.000618	CcSEcCtD
Dicyclomine—Rash—Lovastatin—coronary artery disease	0.00041	0.000618	CcSEcCtD
Dicyclomine—Dermatitis—Lovastatin—coronary artery disease	0.00041	0.000617	CcSEcCtD
Dicyclomine—Dyspepsia—Losartan—coronary artery disease	0.000409	0.000616	CcSEcCtD
Dicyclomine—Feeling abnormal—Perindopril—coronary artery disease	0.000408	0.000615	CcSEcCtD
Dicyclomine—Headache—Lovastatin—coronary artery disease	0.000408	0.000614	CcSEcCtD
Dicyclomine—Pruritus—Valsartan—coronary artery disease	0.000407	0.000612	CcSEcCtD
Dicyclomine—Dry mouth—Ramipril—coronary artery disease	0.000407	0.000612	CcSEcCtD
Dicyclomine—Vomiting—Ezetimibe—coronary artery disease	0.000406	0.000611	CcSEcCtD
Dicyclomine—Hypersensitivity—Pravastatin—coronary artery disease	0.000405	0.00061	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Perindopril—coronary artery disease	0.000405	0.00061	CcSEcCtD
Dicyclomine—Angioedema—Lisinopril—coronary artery disease	0.000405	0.000609	CcSEcCtD
Dicyclomine—Pruritus—Olmesartan—coronary artery disease	0.000405	0.000609	CcSEcCtD
Dicyclomine—Decreased appetite—Losartan—coronary artery disease	0.000404	0.000608	CcSEcCtD
Dicyclomine—Abdominal pain—Captopril—coronary artery disease	0.000404	0.000608	CcSEcCtD
Dicyclomine—Dizziness—Simvastatin—coronary artery disease	0.000403	0.000606	CcSEcCtD
Dicyclomine—Rash—Ezetimibe—coronary artery disease	0.000402	0.000606	CcSEcCtD
Dicyclomine—Dermatitis—Ezetimibe—coronary artery disease	0.000402	0.000605	CcSEcCtD
Dicyclomine—Confusional state—Ramipril—coronary artery disease	0.000402	0.000605	CcSEcCtD
Dicyclomine—Discomfort—Timolol—coronary artery disease	0.000402	0.000605	CcSEcCtD
Dicyclomine—Asthenia—Niacin—coronary artery disease	0.000401	0.000604	CcSEcCtD
Dicyclomine—Fatigue—Losartan—coronary artery disease	0.000401	0.000603	CcSEcCtD
Dicyclomine—Headache—Ezetimibe—coronary artery disease	0.0004	0.000602	CcSEcCtD
Dicyclomine—Malaise—Lisinopril—coronary artery disease	0.0004	0.000601	CcSEcCtD
Dicyclomine—Anaphylactic shock—Ramipril—coronary artery disease	0.000399	0.0006	CcSEcCtD
Dicyclomine—Oedema—Ramipril—coronary artery disease	0.000399	0.0006	CcSEcCtD
Dicyclomine—Dry mouth—Timolol—coronary artery disease	0.000398	0.000599	CcSEcCtD
Dicyclomine—Pain—Losartan—coronary artery disease	0.000398	0.000599	CcSEcCtD
Dicyclomine—Constipation—Losartan—coronary artery disease	0.000398	0.000599	CcSEcCtD
Dicyclomine—Syncope—Lisinopril—coronary artery disease	0.000397	0.000598	CcSEcCtD
Dicyclomine—Vomiting—Eplerenone—coronary artery disease	0.000397	0.000598	CcSEcCtD
Dicyclomine—Feeling abnormal—Furosemide—coronary artery disease	0.000397	0.000598	CcSEcCtD
Dicyclomine—Nausea—Fenofibrate—coronary artery disease	0.000396	0.000596	CcSEcCtD
Dicyclomine—Pruritus—Niacin—coronary artery disease	0.000395	0.000595	CcSEcCtD
Dicyclomine—Asthenia—Pravastatin—coronary artery disease	0.000395	0.000594	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Furosemide—coronary artery disease	0.000394	0.000593	CcSEcCtD
Dicyclomine—Rash—Eplerenone—coronary artery disease	0.000394	0.000593	CcSEcCtD
Dicyclomine—Urticaria—Perindopril—coronary artery disease	0.000394	0.000593	CcSEcCtD
Dicyclomine—Hypersensitivity—Trandolapril—coronary artery disease	0.000394	0.000593	CcSEcCtD
Dicyclomine—Dermatitis—Eplerenone—coronary artery disease	0.000394	0.000592	CcSEcCtD
Dicyclomine—Confusional state—Timolol—coronary artery disease	0.000393	0.000592	CcSEcCtD
Dicyclomine—Shock—Ramipril—coronary artery disease	0.000392	0.00059	CcSEcCtD
Dicyclomine—Hypersensitivity—Enalapril—coronary artery disease	0.000392	0.00059	CcSEcCtD
Dicyclomine—Abdominal pain—Perindopril—coronary artery disease	0.000392	0.00059	CcSEcCtD
Dicyclomine—Palpitations—Lisinopril—coronary artery disease	0.000392	0.000589	CcSEcCtD
Dicyclomine—Headache—Eplerenone—coronary artery disease	0.000391	0.000589	CcSEcCtD
Dicyclomine—Nervous system disorder—Ramipril—coronary artery disease	0.000391	0.000589	CcSEcCtD
Dicyclomine—Oedema—Timolol—coronary artery disease	0.00039	0.000587	CcSEcCtD
Dicyclomine—Anaphylactic shock—Timolol—coronary artery disease	0.00039	0.000587	CcSEcCtD
Dicyclomine—Pruritus—Pravastatin—coronary artery disease	0.000389	0.000586	CcSEcCtD
Dicyclomine—Loss of consciousness—Lisinopril—coronary artery disease	0.000389	0.000586	CcSEcCtD
Dicyclomine—Nausea—Clopidogrel—coronary artery disease	0.000389	0.000586	CcSEcCtD
Dicyclomine—Tachycardia—Ramipril—coronary artery disease	0.000389	0.000586	CcSEcCtD
Dicyclomine—Vomiting—Simvastatin—coronary artery disease	0.000387	0.000583	CcSEcCtD
Dicyclomine—Hypersensitivity—Telmisartan—coronary artery disease	0.000387	0.000582	CcSEcCtD
Dicyclomine—Nausea—Lovastatin—coronary artery disease	0.000387	0.000582	CcSEcCtD
Dicyclomine—Rash—Simvastatin—coronary artery disease	0.000384	0.000578	CcSEcCtD
Dicyclomine—Dermatitis—Simvastatin—coronary artery disease	0.000383	0.000577	CcSEcCtD
Dicyclomine—Asthenia—Trandolapril—coronary artery disease	0.000383	0.000577	CcSEcCtD
Dicyclomine—Shock—Timolol—coronary artery disease	0.000383	0.000577	CcSEcCtD
Dicyclomine—Feeling abnormal—Losartan—coronary artery disease	0.000383	0.000577	CcSEcCtD
Dicyclomine—Urticaria—Furosemide—coronary artery disease	0.000383	0.000576	CcSEcCtD
Dicyclomine—Nervous system disorder—Timolol—coronary artery disease	0.000382	0.000575	CcSEcCtD
Dicyclomine—Asthenia—Enalapril—coronary artery disease	0.000382	0.000575	CcSEcCtD
Dicyclomine—Headache—Simvastatin—coronary artery disease	0.000381	0.000574	CcSEcCtD
Dicyclomine—Abdominal pain—Furosemide—coronary artery disease	0.000381	0.000573	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Losartan—coronary artery disease	0.00038	0.000572	CcSEcCtD
Dicyclomine—Dizziness—Valsartan—coronary artery disease	0.00038	0.000572	CcSEcCtD
Dicyclomine—Anorexia—Ramipril—coronary artery disease	0.00038	0.000572	CcSEcCtD
Dicyclomine—Nausea—Ezetimibe—coronary artery disease	0.000379	0.000571	CcSEcCtD
Dicyclomine—Dizziness—Olmesartan—coronary artery disease	0.000378	0.00057	CcSEcCtD
Dicyclomine—Pruritus—Trandolapril—coronary artery disease	0.000378	0.000569	CcSEcCtD
Dicyclomine—Asthenia—Telmisartan—coronary artery disease	0.000377	0.000567	CcSEcCtD
Dicyclomine—Pruritus—Enalapril—coronary artery disease	0.000377	0.000567	CcSEcCtD
Dicyclomine—Discomfort—Lisinopril—coronary artery disease	0.000373	0.000561	CcSEcCtD
Dicyclomine—Anorexia—Timolol—coronary artery disease	0.000372	0.000559	CcSEcCtD
Dicyclomine—Pruritus—Telmisartan—coronary artery disease	0.000371	0.000559	CcSEcCtD
Dicyclomine—Nausea—Eplerenone—coronary artery disease	0.000371	0.000559	CcSEcCtD
Dicyclomine—Dizziness—Niacin—coronary artery disease	0.00037	0.000556	CcSEcCtD
Dicyclomine—Urticaria—Losartan—coronary artery disease	0.000369	0.000556	CcSEcCtD
Dicyclomine—Dry mouth—Lisinopril—coronary artery disease	0.000369	0.000555	CcSEcCtD
Dicyclomine—Abdominal pain—Losartan—coronary artery disease	0.000368	0.000553	CcSEcCtD
Dicyclomine—Asthenia—Captopril—coronary artery disease	0.000366	0.000551	CcSEcCtD
Dicyclomine—Vomiting—Valsartan—coronary artery disease	0.000366	0.00055	CcSEcCtD
Dicyclomine—Confusional state—Lisinopril—coronary artery disease	0.000365	0.000549	CcSEcCtD
Dicyclomine—Dizziness—Pravastatin—coronary artery disease	0.000364	0.000548	CcSEcCtD
Dicyclomine—Vomiting—Olmesartan—coronary artery disease	0.000364	0.000548	CcSEcCtD
Dicyclomine—Rash—Valsartan—coronary artery disease	0.000362	0.000546	CcSEcCtD
Dicyclomine—Dermatitis—Valsartan—coronary artery disease	0.000362	0.000545	CcSEcCtD
Dicyclomine—Nausea—Simvastatin—coronary artery disease	0.000362	0.000544	CcSEcCtD
Dicyclomine—Anaphylactic shock—Lisinopril—coronary artery disease	0.000362	0.000544	CcSEcCtD
Dicyclomine—Oedema—Lisinopril—coronary artery disease	0.000362	0.000544	CcSEcCtD
Dicyclomine—Pruritus—Captopril—coronary artery disease	0.000361	0.000544	CcSEcCtD
Dicyclomine—Rash—Olmesartan—coronary artery disease	0.000361	0.000543	CcSEcCtD
Dicyclomine—Insomnia—Ramipril—coronary artery disease	0.000361	0.000543	CcSEcCtD
Dicyclomine—Dermatitis—Olmesartan—coronary artery disease	0.00036	0.000543	CcSEcCtD
Dicyclomine—Headache—Valsartan—coronary artery disease	0.00036	0.000542	CcSEcCtD
Dicyclomine—Headache—Olmesartan—coronary artery disease	0.000358	0.00054	CcSEcCtD
Dicyclomine—Paraesthesia—Ramipril—coronary artery disease	0.000358	0.000539	CcSEcCtD
Dicyclomine—Shock—Lisinopril—coronary artery disease	0.000356	0.000535	CcSEcCtD
Dicyclomine—Asthenia—Perindopril—coronary artery disease	0.000356	0.000535	CcSEcCtD
Dicyclomine—Dyspnoea—Ramipril—coronary artery disease	0.000355	0.000535	CcSEcCtD
Dicyclomine—Vomiting—Niacin—coronary artery disease	0.000355	0.000535	CcSEcCtD
Dicyclomine—Hypersensitivity—Furosemide—coronary artery disease	0.000355	0.000534	CcSEcCtD
Dicyclomine—Somnolence—Ramipril—coronary artery disease	0.000354	0.000534	CcSEcCtD
Dicyclomine—Dizziness—Trandolapril—coronary artery disease	0.000353	0.000532	CcSEcCtD
Dicyclomine—Tachycardia—Lisinopril—coronary artery disease	0.000353	0.000531	CcSEcCtD
Dicyclomine—Insomnia—Timolol—coronary artery disease	0.000353	0.000531	CcSEcCtD
Dicyclomine—Rash—Niacin—coronary artery disease	0.000352	0.000531	CcSEcCtD
Dicyclomine—Dermatitis—Niacin—coronary artery disease	0.000352	0.00053	CcSEcCtD
Dicyclomine—Dizziness—Enalapril—coronary artery disease	0.000352	0.00053	CcSEcCtD
Dicyclomine—Dyspepsia—Ramipril—coronary artery disease	0.000351	0.000528	CcSEcCtD
Dicyclomine—Pruritus—Perindopril—coronary artery disease	0.000351	0.000528	CcSEcCtD
Dicyclomine—Headache—Niacin—coronary artery disease	0.00035	0.000527	CcSEcCtD
Dicyclomine—Paraesthesia—Timolol—coronary artery disease	0.00035	0.000527	CcSEcCtD
Dicyclomine—Vomiting—Pravastatin—coronary artery disease	0.00035	0.000527	CcSEcCtD
Dicyclomine—Dyspnoea—Timolol—coronary artery disease	0.000347	0.000523	CcSEcCtD
Dicyclomine—Dizziness—Telmisartan—coronary artery disease	0.000347	0.000523	CcSEcCtD
Dicyclomine—Rash—Pravastatin—coronary artery disease	0.000347	0.000522	CcSEcCtD
Dicyclomine—Dermatitis—Pravastatin—coronary artery disease	0.000347	0.000522	CcSEcCtD
Dicyclomine—Decreased appetite—Ramipril—coronary artery disease	0.000347	0.000522	CcSEcCtD
Dicyclomine—Somnolence—Timolol—coronary artery disease	0.000346	0.000522	CcSEcCtD
Dicyclomine—Asthenia—Furosemide—coronary artery disease	0.000346	0.00052	CcSEcCtD
Dicyclomine—Headache—Pravastatin—coronary artery disease	0.000345	0.000519	CcSEcCtD
Dicyclomine—Anorexia—Lisinopril—coronary artery disease	0.000345	0.000519	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Ramipril—coronary artery disease	0.000344	0.000518	CcSEcCtD
Dicyclomine—Fatigue—Ramipril—coronary artery disease	0.000344	0.000517	CcSEcCtD
Dicyclomine—Dyspepsia—Timolol—coronary artery disease	0.000343	0.000516	CcSEcCtD
Dicyclomine—Hypersensitivity—Losartan—coronary artery disease	0.000343	0.000516	CcSEcCtD
Dicyclomine—Nausea—Valsartan—coronary artery disease	0.000341	0.000514	CcSEcCtD
Dicyclomine—Pruritus—Furosemide—coronary artery disease	0.000341	0.000513	CcSEcCtD
Dicyclomine—Constipation—Ramipril—coronary artery disease	0.000341	0.000513	CcSEcCtD
Dicyclomine—Nausea—Olmesartan—coronary artery disease	0.00034	0.000512	CcSEcCtD
Dicyclomine—Vomiting—Trandolapril—coronary artery disease	0.00034	0.000512	CcSEcCtD
Dicyclomine—Decreased appetite—Timolol—coronary artery disease	0.000339	0.00051	CcSEcCtD
Dicyclomine—Vomiting—Enalapril—coronary artery disease	0.000338	0.00051	CcSEcCtD
Dicyclomine—Dizziness—Captopril—coronary artery disease	0.000338	0.000508	CcSEcCtD
Dicyclomine—Rash—Trandolapril—coronary artery disease	0.000337	0.000507	CcSEcCtD
Dicyclomine—Dermatitis—Trandolapril—coronary artery disease	0.000337	0.000507	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Timolol—coronary artery disease	0.000336	0.000507	CcSEcCtD
Dicyclomine—Fatigue—Timolol—coronary artery disease	0.000336	0.000506	CcSEcCtD
Dicyclomine—Rash—Enalapril—coronary artery disease	0.000336	0.000505	CcSEcCtD
Dicyclomine—Dermatitis—Enalapril—coronary artery disease	0.000335	0.000505	CcSEcCtD
Dicyclomine—Headache—Trandolapril—coronary artery disease	0.000335	0.000504	CcSEcCtD
Dicyclomine—Vomiting—Telmisartan—coronary artery disease	0.000334	0.000503	CcSEcCtD
Dicyclomine—Asthenia—Losartan—coronary artery disease	0.000334	0.000502	CcSEcCtD
Dicyclomine—Headache—Enalapril—coronary artery disease	0.000333	0.000502	CcSEcCtD
Dicyclomine—Pain—Timolol—coronary artery disease	0.000333	0.000502	CcSEcCtD
Dicyclomine—Nausea—Niacin—coronary artery disease	0.000332	0.0005	CcSEcCtD
Dicyclomine—Rash—Telmisartan—coronary artery disease	0.000331	0.000498	CcSEcCtD
Dicyclomine—Dermatitis—Telmisartan—coronary artery disease	0.000331	0.000498	CcSEcCtD
Dicyclomine—Pruritus—Losartan—coronary artery disease	0.000329	0.000495	CcSEcCtD
Dicyclomine—Headache—Telmisartan—coronary artery disease	0.000329	0.000495	CcSEcCtD
Dicyclomine—Feeling abnormal—Ramipril—coronary artery disease	0.000329	0.000495	CcSEcCtD
Dicyclomine—Dizziness—Perindopril—coronary artery disease	0.000328	0.000493	CcSEcCtD
Dicyclomine—Insomnia—Lisinopril—coronary artery disease	0.000327	0.000492	CcSEcCtD
Dicyclomine—Nausea—Pravastatin—coronary artery disease	0.000327	0.000492	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Ramipril—coronary artery disease	0.000326	0.000491	CcSEcCtD
Dicyclomine—Paraesthesia—Lisinopril—coronary artery disease	0.000325	0.000489	CcSEcCtD
Dicyclomine—Vomiting—Captopril—coronary artery disease	0.000325	0.000489	CcSEcCtD
Dicyclomine—Dyspnoea—Lisinopril—coronary artery disease	0.000322	0.000485	CcSEcCtD
Dicyclomine—Rash—Captopril—coronary artery disease	0.000322	0.000485	CcSEcCtD
Dicyclomine—Dermatitis—Captopril—coronary artery disease	0.000322	0.000484	CcSEcCtD
Dicyclomine—Somnolence—Lisinopril—coronary artery disease	0.000321	0.000484	CcSEcCtD
Dicyclomine—Feeling abnormal—Timolol—coronary artery disease	0.000321	0.000483	CcSEcCtD
Dicyclomine—Headache—Captopril—coronary artery disease	0.00032	0.000481	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Timolol—coronary artery disease	0.000319	0.00048	CcSEcCtD
Dicyclomine—Dizziness—Furosemide—coronary artery disease	0.000319	0.00048	CcSEcCtD
Dicyclomine—Dyspepsia—Lisinopril—coronary artery disease	0.000318	0.000479	CcSEcCtD
Dicyclomine—Nausea—Trandolapril—coronary artery disease	0.000317	0.000478	CcSEcCtD
Dicyclomine—Urticaria—Ramipril—coronary artery disease	0.000317	0.000477	CcSEcCtD
Dicyclomine—Nausea—Enalapril—coronary artery disease	0.000316	0.000476	CcSEcCtD
Dicyclomine—Vomiting—Perindopril—coronary artery disease	0.000315	0.000474	CcSEcCtD
Dicyclomine—Abdominal pain—Ramipril—coronary artery disease	0.000315	0.000474	CcSEcCtD
Dicyclomine—Decreased appetite—Lisinopril—coronary artery disease	0.000314	0.000473	CcSEcCtD
Dicyclomine—Rash—Perindopril—coronary artery disease	0.000313	0.000471	CcSEcCtD
Dicyclomine—Dermatitis—Perindopril—coronary artery disease	0.000312	0.00047	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Lisinopril—coronary artery disease	0.000312	0.00047	CcSEcCtD
Dicyclomine—Nausea—Telmisartan—coronary artery disease	0.000312	0.000469	CcSEcCtD
Dicyclomine—Fatigue—Lisinopril—coronary artery disease	0.000312	0.000469	CcSEcCtD
Dicyclomine—Headache—Perindopril—coronary artery disease	0.000311	0.000467	CcSEcCtD
Dicyclomine—Urticaria—Timolol—coronary artery disease	0.00031	0.000466	CcSEcCtD
Dicyclomine—Pain—Lisinopril—coronary artery disease	0.000309	0.000465	CcSEcCtD
Dicyclomine—Constipation—Lisinopril—coronary artery disease	0.000309	0.000465	CcSEcCtD
Dicyclomine—Abdominal pain—Timolol—coronary artery disease	0.000308	0.000464	CcSEcCtD
Dicyclomine—Dizziness—Losartan—coronary artery disease	0.000307	0.000463	CcSEcCtD
Dicyclomine—Vomiting—Furosemide—coronary artery disease	0.000306	0.000461	CcSEcCtD
Dicyclomine—Rash—Furosemide—coronary artery disease	0.000304	0.000457	CcSEcCtD
Dicyclomine—Dermatitis—Furosemide—coronary artery disease	0.000304	0.000457	CcSEcCtD
Dicyclomine—Nausea—Captopril—coronary artery disease	0.000303	0.000457	CcSEcCtD
Dicyclomine—Headache—Furosemide—coronary artery disease	0.000302	0.000454	CcSEcCtD
Dicyclomine—Feeling abnormal—Lisinopril—coronary artery disease	0.000298	0.000449	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Lisinopril—coronary artery disease	0.000296	0.000445	CcSEcCtD
Dicyclomine—Vomiting—Losartan—coronary artery disease	0.000296	0.000445	CcSEcCtD
Dicyclomine—Nausea—Perindopril—coronary artery disease	0.000294	0.000443	CcSEcCtD
Dicyclomine—Hypersensitivity—Ramipril—coronary artery disease	0.000294	0.000442	CcSEcCtD
Dicyclomine—Rash—Losartan—coronary artery disease	0.000293	0.000441	CcSEcCtD
Dicyclomine—Dermatitis—Losartan—coronary artery disease	0.000293	0.000441	CcSEcCtD
Dicyclomine—Headache—Losartan—coronary artery disease	0.000291	0.000438	CcSEcCtD
Dicyclomine—Urticaria—Lisinopril—coronary artery disease	0.000287	0.000432	CcSEcCtD
Dicyclomine—Hypersensitivity—Timolol—coronary artery disease	0.000287	0.000432	CcSEcCtD
Dicyclomine—Nausea—Furosemide—coronary artery disease	0.000286	0.000431	CcSEcCtD
Dicyclomine—Asthenia—Ramipril—coronary artery disease	0.000286	0.000431	CcSEcCtD
Dicyclomine—Abdominal pain—Lisinopril—coronary artery disease	0.000286	0.00043	CcSEcCtD
Dicyclomine—Pruritus—Ramipril—coronary artery disease	0.000282	0.000425	CcSEcCtD
Dicyclomine—Asthenia—Timolol—coronary artery disease	0.00028	0.000421	CcSEcCtD
Dicyclomine—Nausea—Losartan—coronary artery disease	0.000276	0.000416	CcSEcCtD
Dicyclomine—Pruritus—Timolol—coronary artery disease	0.000276	0.000415	CcSEcCtD
Dicyclomine—Hypersensitivity—Lisinopril—coronary artery disease	0.000266	0.000401	CcSEcCtD
Dicyclomine—Dizziness—Ramipril—coronary artery disease	0.000264	0.000397	CcSEcCtD
Dicyclomine—Asthenia—Lisinopril—coronary artery disease	0.000259	0.000391	CcSEcCtD
Dicyclomine—Dizziness—Timolol—coronary artery disease	0.000258	0.000388	CcSEcCtD
Dicyclomine—Pruritus—Lisinopril—coronary artery disease	0.000256	0.000385	CcSEcCtD
Dicyclomine—Vomiting—Ramipril—coronary artery disease	0.000253	0.000382	CcSEcCtD
Dicyclomine—Rash—Ramipril—coronary artery disease	0.000251	0.000378	CcSEcCtD
Dicyclomine—Dermatitis—Ramipril—coronary artery disease	0.000251	0.000378	CcSEcCtD
Dicyclomine—Headache—Ramipril—coronary artery disease	0.00025	0.000376	CcSEcCtD
Dicyclomine—Vomiting—Timolol—coronary artery disease	0.000248	0.000373	CcSEcCtD
Dicyclomine—Rash—Timolol—coronary artery disease	0.000246	0.00037	CcSEcCtD
Dicyclomine—Dermatitis—Timolol—coronary artery disease	0.000246	0.00037	CcSEcCtD
Dicyclomine—Headache—Timolol—coronary artery disease	0.000244	0.000368	CcSEcCtD
Dicyclomine—Dizziness—Lisinopril—coronary artery disease	0.000239	0.00036	CcSEcCtD
Dicyclomine—Nausea—Ramipril—coronary artery disease	0.000237	0.000356	CcSEcCtD
Dicyclomine—Nausea—Timolol—coronary artery disease	0.000232	0.000349	CcSEcCtD
Dicyclomine—Vomiting—Lisinopril—coronary artery disease	0.00023	0.000346	CcSEcCtD
Dicyclomine—Rash—Lisinopril—coronary artery disease	0.000228	0.000343	CcSEcCtD
Dicyclomine—Dermatitis—Lisinopril—coronary artery disease	0.000228	0.000343	CcSEcCtD
Dicyclomine—Headache—Lisinopril—coronary artery disease	0.000227	0.000341	CcSEcCtD
Dicyclomine—Nausea—Lisinopril—coronary artery disease	0.000215	0.000323	CcSEcCtD
Dicyclomine—CYP1A1—Metabolism—ABCA1—coronary artery disease	3.03e-05	9.01e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—POMC—coronary artery disease	3.02e-05	8.99e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—CREB1—coronary artery disease	3.02e-05	8.99e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—AGTR1—coronary artery disease	3.01e-05	8.96e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—CCL2—coronary artery disease	2.99e-05	8.91e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—LPL—coronary artery disease	2.99e-05	8.9e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—IL6R—coronary artery disease	2.98e-05	8.88e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—CCL2—coronary artery disease	2.98e-05	8.88e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CXCL10—coronary artery disease	2.98e-05	8.87e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—IL6R—coronary artery disease	2.97e-05	8.85e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PLG—coronary artery disease	2.97e-05	8.85e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CXCL10—coronary artery disease	2.97e-05	8.84e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PLG—coronary artery disease	2.96e-05	8.82e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—CCL2—coronary artery disease	2.95e-05	8.79e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—IL6R—coronary artery disease	2.94e-05	8.77e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CXCL10—coronary artery disease	2.94e-05	8.76e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PLG—coronary artery disease	2.93e-05	8.73e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—GGT1—coronary artery disease	2.93e-05	8.73e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—GOT1—coronary artery disease	2.93e-05	8.73e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—GPX1—coronary artery disease	2.92e-05	8.69e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—ADRB2—coronary artery disease	2.89e-05	8.61e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—ADRB2—coronary artery disease	2.88e-05	8.59e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PRKCE—coronary artery disease	2.85e-05	8.5e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—ADRB2—coronary artery disease	2.85e-05	8.5e-05	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—JAK2—coronary artery disease	2.85e-05	8.5e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—SOCS1—coronary artery disease	2.85e-05	8.48e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PRKCE—coronary artery disease	2.85e-05	8.48e-05	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—JAK2—coronary artery disease	2.84e-05	8.47e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—S100B—coronary artery disease	2.84e-05	8.46e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—CD36—coronary artery disease	2.84e-05	8.46e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—SOCS1—coronary artery disease	2.84e-05	8.46e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—S100B—coronary artery disease	2.83e-05	8.43e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PRKCE—coronary artery disease	2.82e-05	8.39e-05	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—JAK2—coronary artery disease	2.82e-05	8.39e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—SOCS3—coronary artery disease	2.81e-05	8.38e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—SOCS1—coronary artery disease	2.81e-05	8.37e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PPP2CA—coronary artery disease	2.8e-05	8.35e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—S100B—coronary artery disease	2.8e-05	8.35e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—SOCS3—coronary artery disease	2.8e-05	8.35e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—KITLG—coronary artery disease	2.78e-05	8.28e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—TGFBR2—coronary artery disease	2.78e-05	8.28e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—SOCS3—coronary artery disease	2.78e-05	8.27e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—KITLG—coronary artery disease	2.77e-05	8.25e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—TGFBR2—coronary artery disease	2.77e-05	8.25e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—KITLG—coronary artery disease	2.74e-05	8.17e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—TGFBR2—coronary artery disease	2.74e-05	8.17e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—STAT5A—coronary artery disease	2.72e-05	8.09e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—MMP3—coronary artery disease	2.72e-05	8.09e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—STAT5A—coronary artery disease	2.71e-05	8.07e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—MMP3—coronary artery disease	2.71e-05	8.07e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—MTHFR—coronary artery disease	2.69e-05	8.02e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—STAT5A—coronary artery disease	2.68e-05	7.99e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—MMP3—coronary artery disease	2.68e-05	7.99e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—GSTP1—coronary artery disease	2.63e-05	7.84e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—APOB—coronary artery disease	2.63e-05	7.82e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—APOB—coronary artery disease	2.62e-05	7.8e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PPARGC1A—coronary artery disease	2.61e-05	7.77e-05	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—CXCL8—coronary artery disease	2.6e-05	7.75e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—HMOX1—coronary artery disease	2.6e-05	7.73e-05	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—CXCL8—coronary artery disease	2.6e-05	7.73e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—APOB—coronary artery disease	2.59e-05	7.72e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—JAK2—coronary artery disease	2.59e-05	7.72e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—EDN1—coronary artery disease	2.58e-05	7.7e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—JAK2—coronary artery disease	2.58e-05	7.69e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—EDN1—coronary artery disease	2.58e-05	7.67e-05	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—CXCL8—coronary artery disease	2.57e-05	7.66e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CCL5—coronary artery disease	2.56e-05	7.64e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CAT—coronary artery disease	2.56e-05	7.63e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—JAK2—coronary artery disease	2.56e-05	7.62e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—AGT—coronary artery disease	2.56e-05	7.62e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CCL5—coronary artery disease	2.56e-05	7.61e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—EDN1—coronary artery disease	2.55e-05	7.6e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CCL5—coronary artery disease	2.53e-05	7.54e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CSF2—coronary artery disease	2.53e-05	7.52e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—FGF1—coronary artery disease	2.53e-05	7.52e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—FGF1—coronary artery disease	2.52e-05	7.5e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CSF2—coronary artery disease	2.52e-05	7.5e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—LPL—coronary artery disease	2.51e-05	7.47e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—APOE—coronary artery disease	2.51e-05	7.46e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—LPL—coronary artery disease	2.5e-05	7.44e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—FGF1—coronary artery disease	2.49e-05	7.43e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CSF2—coronary artery disease	2.49e-05	7.43e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—APOB—coronary artery disease	2.49e-05	7.41e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—MEF2C—coronary artery disease	2.48e-05	7.4e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—RPS6KB1—coronary artery disease	2.48e-05	7.4e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—MEF2C—coronary artery disease	2.48e-05	7.38e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—RPS6KB1—coronary artery disease	2.48e-05	7.38e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—APOA1—coronary artery disease	2.48e-05	7.38e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—LPL—coronary artery disease	2.47e-05	7.37e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—MEF2C—coronary artery disease	2.45e-05	7.31e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—RPS6KB1—coronary artery disease	2.45e-05	7.31e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—ITGB3—coronary artery disease	2.42e-05	7.21e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—GSTM1—coronary artery disease	2.42e-05	7.21e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—ITGB3—coronary artery disease	2.41e-05	7.19e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—ITGB3—coronary artery disease	2.39e-05	7.12e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—LPL—coronary artery disease	2.37e-05	7.07e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—CXCL8—coronary artery disease	2.36e-05	7.04e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—CXCL8—coronary artery disease	2.36e-05	7.02e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PPP2CA—coronary artery disease	2.35e-05	7.01e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PPP2CA—coronary artery disease	2.34e-05	6.98e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—CXCL8—coronary artery disease	2.33e-05	6.95e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PPP2CA—coronary artery disease	2.32e-05	6.92e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—GPX1—coronary artery disease	2.32e-05	6.9e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PRKCD—coronary artery disease	2.31e-05	6.88e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PRKCD—coronary artery disease	2.3e-05	6.86e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PRKCD—coronary artery disease	2.28e-05	6.79e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—HTR2A—coronary artery disease	2.26e-05	6.73e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—C3—coronary artery disease	2.26e-05	6.72e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CD36—coronary artery disease	2.26e-05	6.72e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—HTR2A—coronary artery disease	2.25e-05	6.71e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—C3—coronary artery disease	2.25e-05	6.7e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—HTR2A—coronary artery disease	2.23e-05	6.65e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—C3—coronary artery disease	2.23e-05	6.64e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PPP2CA—coronary artery disease	2.23e-05	6.64e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PPARG—coronary artery disease	2.18e-05	6.5e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—HIF1A—coronary artery disease	2.15e-05	6.41e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—POMC—coronary artery disease	2.15e-05	6.41e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—HIF1A—coronary artery disease	2.15e-05	6.39e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—AGT—coronary artery disease	2.14e-05	6.39e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—AGT—coronary artery disease	2.14e-05	6.37e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—MTHFR—coronary artery disease	2.14e-05	6.37e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—HIF1A—coronary artery disease	2.13e-05	6.33e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—AGT—coronary artery disease	2.12e-05	6.31e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—APOE—coronary artery disease	2.1e-05	6.26e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—LEP—coronary artery disease	2.1e-05	6.26e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—LEP—coronary artery disease	2.09e-05	6.24e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—APOE—coronary artery disease	2.09e-05	6.24e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—APOA1—coronary artery disease	2.08e-05	6.19e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—APOE—coronary artery disease	2.07e-05	6.18e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—LEP—coronary artery disease	2.07e-05	6.18e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—APOA1—coronary artery disease	2.07e-05	6.17e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—KDR—coronary artery disease	2.06e-05	6.13e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—KDR—coronary artery disease	2.05e-05	6.11e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—APOA1—coronary artery disease	2.05e-05	6.11e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—MAPK14—coronary artery disease	2.05e-05	6.09e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—MAPK14—coronary artery disease	2.04e-05	6.07e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—KDR—coronary artery disease	2.03e-05	6.05e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—AGT—coronary artery disease	2.03e-05	6.05e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—MAPK14—coronary artery disease	2.02e-05	6.01e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—ESR1—coronary artery disease	2.01e-05	5.98e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—ESR1—coronary artery disease	2e-05	5.96e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—APOE—coronary artery disease	1.99e-05	5.93e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—F2—coronary artery disease	1.98e-05	5.9e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—FN1—coronary artery disease	1.98e-05	5.9e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—ESR1—coronary artery disease	1.98e-05	5.9e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—F2—coronary artery disease	1.98e-05	5.88e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—FN1—coronary artery disease	1.98e-05	5.88e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—IL6ST—coronary artery disease	1.97e-05	5.88e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—IL6ST—coronary artery disease	1.97e-05	5.86e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—APOA1—coronary artery disease	1.97e-05	5.86e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—ALB—coronary artery disease	1.96e-05	5.84e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—NFKBIA—coronary artery disease	1.96e-05	5.83e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—FN1—coronary artery disease	1.96e-05	5.83e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—F2—coronary artery disease	1.96e-05	5.83e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—NFKBIA—coronary artery disease	1.95e-05	5.81e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—IL6ST—coronary artery disease	1.95e-05	5.8e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—NFKBIA—coronary artery disease	1.93e-05	5.76e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—KIT—coronary artery disease	1.9e-05	5.65e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—KIT—coronary artery disease	1.89e-05	5.63e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.88e-05	5.61e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—NOS3—coronary artery disease	1.88e-05	5.59e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—KIT—coronary artery disease	1.87e-05	5.58e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—GSK3B—coronary artery disease	1.82e-05	5.42e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—GSK3B—coronary artery disease	1.81e-05	5.4e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—POMC—coronary artery disease	1.81e-05	5.38e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CREB1—coronary artery disease	1.81e-05	5.38e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CREB1—coronary artery disease	1.8e-05	5.36e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—POMC—coronary artery disease	1.8e-05	5.36e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—GSK3B—coronary artery disease	1.8e-05	5.35e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—POMC—coronary artery disease	1.78e-05	5.31e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CREB1—coronary artery disease	1.78e-05	5.31e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CCL2—coronary artery disease	1.77e-05	5.26e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—IL6R—coronary artery disease	1.76e-05	5.25e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CCL2—coronary artery disease	1.76e-05	5.25e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—IL6R—coronary artery disease	1.76e-05	5.23e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CCL2—coronary artery disease	1.74e-05	5.19e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—IL6R—coronary artery disease	1.74e-05	5.18e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—IGF1—coronary artery disease	1.74e-05	5.17e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PPARG—coronary artery disease	1.73e-05	5.16e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—IGF1—coronary artery disease	1.73e-05	5.16e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—MAPK1—coronary artery disease	1.73e-05	5.15e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—MAPK1—coronary artery disease	1.72e-05	5.13e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PTGS2—coronary artery disease	1.72e-05	5.11e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—IGF1—coronary artery disease	1.71e-05	5.11e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—POMC—coronary artery disease	1.71e-05	5.09e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—MAPK1—coronary artery disease	1.71e-05	5.08e-05	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—PIK3CA—coronary artery disease	1.65e-05	4.92e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—SERPINE1—coronary artery disease	1.65e-05	4.91e-05	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—PIK3CA—coronary artery disease	1.65e-05	4.9e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—SERPINE1—coronary artery disease	1.64e-05	4.9e-05	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—PIK3CA—coronary artery disease	1.63e-05	4.86e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—SERPINE1—coronary artery disease	1.63e-05	4.85e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—FGF2—coronary artery disease	1.6e-05	4.76e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—FGF2—coronary artery disease	1.59e-05	4.74e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—FGF2—coronary artery disease	1.58e-05	4.69e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—NOS3—coronary artery disease	1.57e-05	4.69e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—NOS3—coronary artery disease	1.57e-05	4.67e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—ALB—coronary artery disease	1.56e-05	4.64e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—NOS3—coronary artery disease	1.55e-05	4.63e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—JAK2—coronary artery disease	1.53e-05	4.56e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—JAK2—coronary artery disease	1.53e-05	4.54e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—JAK2—coronary artery disease	1.51e-05	4.5e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—PIK3CA—coronary artery disease	1.5e-05	4.47e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—PIK3CA—coronary artery disease	1.49e-05	4.45e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—NOS3—coronary artery disease	1.49e-05	4.44e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—PIK3CA—coronary artery disease	1.48e-05	4.41e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CXCL8—coronary artery disease	1.4e-05	4.16e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CXCL8—coronary artery disease	1.39e-05	4.15e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CXCL8—coronary artery disease	1.38e-05	4.11e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PTGS2—coronary artery disease	1.36e-05	4.06e-05	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—AKT1—coronary artery disease	1.35e-05	4.02e-05	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—AKT1—coronary artery disease	1.34e-05	4.01e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CASP3—coronary artery disease	1.34e-05	3.98e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CASP3—coronary artery disease	1.33e-05	3.97e-05	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—AKT1—coronary artery disease	1.33e-05	3.97e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—IL6—coronary artery disease	1.33e-05	3.96e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—IL6—coronary artery disease	1.32e-05	3.94e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CASP3—coronary artery disease	1.32e-05	3.93e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—IL6—coronary artery disease	1.31e-05	3.9e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CCND1—coronary artery disease	1.3e-05	3.88e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CCND1—coronary artery disease	1.3e-05	3.86e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CCND1—coronary artery disease	1.28e-05	3.83e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—MMP9—coronary artery disease	1.26e-05	3.76e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—MMP9—coronary artery disease	1.26e-05	3.75e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—MMP9—coronary artery disease	1.25e-05	3.71e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—AKT1—coronary artery disease	1.23e-05	3.65e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—AKT1—coronary artery disease	1.22e-05	3.64e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—AKT1—coronary artery disease	1.21e-05	3.6e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—VEGFA—coronary artery disease	1.13e-05	3.38e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—VEGFA—coronary artery disease	1.13e-05	3.37e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—VEGFA—coronary artery disease	1.12e-05	3.34e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PIK3CA—coronary artery disease	1.06e-05	3.15e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—TGFB1—coronary artery disease	1.04e-05	3.1e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—TGFB1—coronary artery disease	1.04e-05	3.09e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—TGFB1—coronary artery disease	1.03e-05	3.06e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—MAPK1—coronary artery disease	1.02e-05	3.04e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—MAPK1—coronary artery disease	1.02e-05	3.03e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—MAPK1—coronary artery disease	1.01e-05	3e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PIK3CA—coronary artery disease	8.86e-06	2.64e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PIK3CA—coronary artery disease	8.83e-06	2.63e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PIK3CA—coronary artery disease	8.75e-06	2.61e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—AKT1—coronary artery disease	8.63e-06	2.57e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PIK3CA—coronary artery disease	8.39e-06	2.5e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—IL6—coronary artery disease	7.84e-06	2.34e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—IL6—coronary artery disease	7.82e-06	2.33e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—IL6—coronary artery disease	7.74e-06	2.31e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—AKT1—coronary artery disease	7.24e-06	2.16e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—AKT1—coronary artery disease	7.21e-06	2.15e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—AKT1—coronary artery disease	7.14e-06	2.13e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—AKT1—coronary artery disease	6.85e-06	2.04e-05	CbGpPWpGaD
